Page last updated: 2024-12-09

antofine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

antofine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(-)-antofine : An organic heteropentacyclic compound that is (13aR)-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. It is an alkaloid produced by relatives of the milkweed family and exhibits antiviral, anti-inflammatory, antiadipogenic and antitumorigenic activities. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID639288
CHEMBL ID228286
CHEBI ID143911
SCHEMBL ID12780400
MeSH IDM0448651

Synonyms (20)

Synonym
2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline
dibenzo[f,h]pyrrolo[1,2-b]isoquinoline, 9,11,12,13,13a,14-hexahydro-2,3,6-trimethoxy-, (13ar)-
inchi=1/c23h25no3/c1-25-15-6-7-16-18(10-15)20-12-23(27-3)22(26-2)11-19(20)17-9-14-5-4-8-24(14)13-21(16)17/h6-7,10-12,14h,4-5,8-9,13h2,1-3h3/t14-/m1/s
7-demethoxytylophorine
CHEMBL228286
32671-82-2
9,11,12,13,13a,14-hexahydro-2,3,6-trimethoxydibenzo[f,h]pyrrolo[1,2-b]isoquinoline
2,3,6-trimethoxy-9,10,11,12,12a,13-hexahydro-9a-aza-cyclopenta[b]triphenylene
(13ar)-2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline
(-)-antofine
(r)-(-)-antofine
antofine
CHEBI:143911
(r)-antofine
(r)-2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline
(13ar)-2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f]indolizine
SCHEMBL12780400
DTXSID301318734
CS-0139037
HY-N8052

Research Excerpts

Overview

Antofine is a phenanthroindolizidine alkaloid isolated from the root of Cynanchum paniculatum Kitagawa (Asclepiadaceae) It is used as an herbal remedy for pain and inflammation.

ExcerptReferenceRelevance
"Antofine (ANTF) is a phenanthroindolizidine alkaloid isolated from the root of Cynanchum paniculatum Kitagawa (Asclepiadaceae), which is used as an herbal remedy for pain and inflammation. "( Anti-adipogenic activity of the naturally occurring phenanthroindolizidine alkaloid antofine via direct suppression of PPARγ expression.
Bae, SJ; Hwang, ES; Jang, EJ; Jeong, H; Jeong, MG; Kim, HK; Kim, S; Lee, SK; Lee, YS, 2014
)
2.07

Treatment

ExcerptReferenceRelevance
"Treatment with antofine for 24h did not result in the induction of apoptotic cell death but moderately induced cell cycle arrest at G0/G1 phase and inhibited the expression of cyclin D1, cyclin E, and CDK4."( Inhibition of cell growth and potentiation of tumor necrosis factor-α (TNF-α)-induced apoptosis by a phenanthroindolizidine alkaloid antofine in human colon cancer cells.
Chung, HJ; Kim, EH; Kim, S; Lee, SK; Min, HY; Park, EJ, 2010
)
0.9

Bioavailability

ExcerptReferenceRelevance
" In particular, a methanesulfonamide analogue of cryptopleurine (5b) exhibited improved bioavailability and significant antitumor activity, which suggests that 5b is a promising new anticancer agent."( Design, Synthesis, and Biological Activity of Sulfonamide Analogues of Antofine and Cryptopleurine as Potent and Orally Active Antitumor Agents.
Kim, EY; Kim, S; Kwon, Y; Lee, H; Lee, K; Lee, SK; Song, J, 2015
)
0.65
"Many lead compounds fail to reach clinical trials despite being potent because of low bioavailability attributed to their insufficient solubility making solubility a primary and crucial factor in early phase drug discovery."( Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.
Baidya, ATK; Das, B; Kumar, R; Mathew, AT; Yadav, AK, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (7)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
phytotoxinAny toxin produced by a plant.
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
antiviral agentA substance that destroys or inhibits replication of viruses.
angiogenesis inhibitorAn agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
organic heteropentacyclic compound
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
alkaloidAny of the naturally occurring, basic nitrogen compounds (mostly heterocyclic) occurring mostly in the plant kingdom, but also found in bacteria, fungi, and animals. By extension, certain neutral compounds biogenetically related to basic alkaloids are also classed as alkaloids. Amino acids, peptides, proteins, nucleotides, nucleic acids, amino sugars and antibiotics are not normally regarded as alkaloids. Compounds in which the nitrogen is exocyclic (dopamine, mescaline, serotonin, etc.) are usually classed as amines rather than alkaloids.
alkaloid antibioticAny alkaloid that has significant antibiotic properties.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (87)

Assay IDTitleYearJournalArticle
AID1092199Antiviral activity against Tobacco mosaic virus (TMV) inoculated in 5-6 growth stage leaf assessed as inhibition effect at 100 ug/mL at 25 degC after 72 hr by half-leaf method2012Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41
Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues.
AID610922Upregulation of CDC6 expression in human CL1-5 cells by cDNA microarray2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents.
AID336105Cytotoxicity against drug-resistant human KB-3-1 cells by MTS/PMS assay2002Journal of natural products, Sep, Volume: 65, Issue:9
In vitro cytotoxic activity of phenanthroindolizidine alkaloids from Cynanchum vincetoxicum and Tylophora tanakae against drug-sensitive and multidrug-resistant cancer cells.
AID1092196In vivo antiviral activity against Tobacco mosaic virus (TMV) pre-inoculated Nicotiana tabacum L. leaves assessed as curative effect at 500 ug/mL measured after 3 to 4 days2012Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41
Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues.
AID698605Cytotoxicity against human A549 cells after 2 hrs by methylene blue staining-based spectrophotometric analysis2012Journal of medicinal chemistry, Aug-09, Volume: 55, Issue:15
Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: design, synthesis, and mechanistic studies.
AID1866030Antiproliferative activity against human A549 cells2022Bioorganic & medicinal chemistry, 02-15, Volume: 56Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.
AID292718Cytotoxicity against human HT1080 cells by SRB assay2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
Synthesis and structure-activity studies of antofine analogues as potential anticancer agents.
AID610918Anticancer activity against human KB cells after 72 hrs by sulforhodamine B assay2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents.
AID1082994Antiviral activity against Tobacco mosaic virus (TMV) assessed as inhibition of viral growth at 1 ug/mL2012Journal of agricultural and food chemistry, Sep-05, Volume: 60, Issue:35
Design, synthesis, and antiviral activity evaluation of phenanthrene-based antofine derivatives.
AID316835Inhibition of RNA synthesis in human HepG cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID316826Inhibition of CRE-mediated transcription in human HepG cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID1112990Antiviral activity against Tobacco mosaic virus (TMV) in tobacco plant leaf assessed as protection effect at 500 ug/ml after 3 to 4 days2013Journal of agricultural and food chemistry, Feb-06, Volume: 61, Issue:5
Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.
AID421643Anticancer activity against human DU145 cells after 72 hrs by SRB assay2009Journal of medicinal chemistry, Aug-27, Volume: 52, Issue:16
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents.
AID1474884Cytotoxicity against human A549 cells after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Design and synthesis of 1,2,3-triazolo-phenanthrene hybrids as cytotoxic agents.
AID421642Anticancer activity against human A549 cells after 72 hrs by SRB assay2009Journal of medicinal chemistry, Aug-27, Volume: 52, Issue:16
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents.
AID741185Thermodynamic solubility of the compound in 1:1 mixture of phosphate buffer:ethanol2013Bioorganic & medicinal chemistry, Feb-15, Volume: 21, Issue:4
Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.
AID1112988Antiviral activity against Tobacco mosaic virus (TMV) in tobacco plant leaf assessed as inactivation effect at 100 ug/ml after 3 to 4 days2013Journal of agricultural and food chemistry, Feb-06, Volume: 61, Issue:5
Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.
AID1251629Cytotoxicity against human Caki1 cells assessed as growth inhibition after 72 hrs by SRB assay2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Design, Synthesis, and Biological Activity of Sulfonamide Analogues of Antofine and Cryptopleurine as Potent and Orally Active Antitumor Agents.
AID698602Cytotoxicity against human KB cells after 2 hrs by methylene blue staining-based spectrophotometric analysis2012Journal of medicinal chemistry, Aug-09, Volume: 55, Issue:15
Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: design, synthesis, and mechanistic studies.
AID1092194In vivo antiviral activity against Tobacco mosaic virus (TMV) inoculated right side of Nicotiana tabacum L. leaves assessed as protection effect at 500 ug/mL preincubated 12 hr before viral challenge measured after 3 to 4 days2012Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41
Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues.
AID610925Upregulation of CDC6 expression in human CL1-5 cells at 0.01 ug/mL by RT-PCR analysis after 24 to 48 hrs2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents.
AID741186Thermodynamic solubility of the compound in phosphate buffer at pH 7.42013Bioorganic & medicinal chemistry, Feb-15, Volume: 21, Issue:4
Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.
AID1092198In vivo antiviral activity against Tobacco mosaic virus (TMV) inoculated left side of Nicotiana tabacum L. leaves assessed as inactivation effect at 500 ug/mL co-incubated with virus measured after 3 to 4 days2012Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41
Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues.
AID741430Cytotoxicity against human SNU638 cells after 72 hrs by SRB assay2013Bioorganic & medicinal chemistry, Feb-15, Volume: 21, Issue:4
Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.
AID1103442Antiviral activity against Tobacco mosaic virus (TMV) inoculated in left side of Nicotiana tabacum L. leaves assessed as inhibition of local lesion number at 50 mg/l measured after 3 to 4 days2005Journal of agricultural and food chemistry, Oct-05, Volume: 53, Issue:20
Synthesis and antiviral activity of novel chiral cyanoacrylate derivatives.
AID1112992Antiviral activity against Tobacco mosaic virus (TMV) in tobacco leaf juice at 100 ug/ml after 72 hr by half-leaf method2013Journal of agricultural and food chemistry, Feb-06, Volume: 61, Issue:5
Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.
AID316824Growth inhibition of human CEM cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID291931Cytotoxicity against multidrug resistant human KB-Vin cells by SRB microtiter plate assay2007Journal of medicinal chemistry, Jul-26, Volume: 50, Issue:15
Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
AID1092195In vivo antiviral activity against Tobacco mosaic virus (TMV) pre-inoculated Nicotiana tabacum L. leaves assessed as curative effect at 100 ug/mL measured after 3 to 4 days2012Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41
Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues.
AID316834Inhibition of protein synthesis in human HepG cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID1082871Antiviral activity against Tobacco mosaic virus (TMV) assessed as inhibition effect at 1 ug/mL2012Journal of agricultural and food chemistry, Jun-13, Volume: 60, Issue:23
Design, synthesis, antiviral activity, and SARs of 14-aminophenanthroindolizidines.
AID316833Inhibition of DNA synthesis in human HepG cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID741237Cytotoxicity against human A549 cells after 72 hrs by SRB assay2013Bioorganic & medicinal chemistry, Feb-15, Volume: 21, Issue:4
Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.
AID1112989Antiviral activity against Tobacco mosaic virus (TMV) in tobacco plant leaf assessed as inactivation effect at 500 ug/ml after 3 to 4 days2013Journal of agricultural and food chemistry, Feb-06, Volume: 61, Issue:5
Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.
AID1112993Antiviral activity against Tobacco mosaic virus (TMV) in tobacco leaf juice at 500 ug/ml after 72 hr by half-leaf method2013Journal of agricultural and food chemistry, Feb-06, Volume: 61, Issue:5
Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.
AID316827Inhibition of AP1-mediated transcription in human HepG cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID1092193In vivo antiviral activity against Tobacco mosaic virus (TMV) inoculated right side of Nicotiana tabacum L. leaves assessed as protection effect at 100 ug/mL preincubated 12 hr before viral challenge measured after 3 to 4 days2012Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41
Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues.
AID610917Anticancer activity against human DU145 cells after 72 hrs by sulforhodamine B assay2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents.
AID291927Cytotoxicity against human A549 cells by SRB microtiter plate assay2007Journal of medicinal chemistry, Jul-26, Volume: 50, Issue:15
Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
AID1092200Antiviral activity against Tobacco mosaic virus (TMV) inoculated in 5-6 growth stage leaf assessed as inhibition effect at 500 ug/mL at 25 degC after 72 hr by half-leaf method2012Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41
Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues.
AID316832Ratio of IC50 for GRE-mediated transcription in human HepG cells to GI50 for human HepG2 cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID1474890Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Design and synthesis of 1,2,3-triazolo-phenanthrene hybrids as cytotoxic agents.
AID1474886Cytotoxicity against human DU145 cells after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Design and synthesis of 1,2,3-triazolo-phenanthrene hybrids as cytotoxic agents.
AID1866020Thermodynamic aqueous solubility of the compound2022Bioorganic & medicinal chemistry, 02-15, Volume: 56Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.
AID316830Ratio of IC50 for CRE-mediated transcription in human HepG cells to GI50 for human HepG2 cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID1251627Cytotoxicity against human SKHEP1 cells assessed as growth inhibition after 72 hrs by SRB assay2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Design, Synthesis, and Biological Activity of Sulfonamide Analogues of Antofine and Cryptopleurine as Potent and Orally Active Antitumor Agents.
AID741196Inhibition of P-gp activity in human paclitaxel-resistant A549 cells assessed as rhodamine 123 accumulation at 10 nM after 72 hrs by FACS analysis (Rvb = 14.4 %)2013Bioorganic & medicinal chemistry, Feb-15, Volume: 21, Issue:4
Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.
AID1251625Cytotoxicity against human SNU638 cells assessed as growth inhibition after 72 hrs by SRB assay2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Design, Synthesis, and Biological Activity of Sulfonamide Analogues of Antofine and Cryptopleurine as Potent and Orally Active Antitumor Agents.
AID1377601Inhibition of P-gp in human A549/PA cells assessed as synergistic cytotoxicity with paclitaxel after 48 hrs by SRB assay2017European journal of medicinal chemistry, Sep-29, Volume: 138Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
AID1103440Antiviral activity against Tobacco mosaic virus (TMV) inoculated in whole leaves of Nicotiana tabacum L. assessed as curative effect measured as local lesion number at 50 mg/l after 3 to 4 days2005Journal of agricultural and food chemistry, Oct-05, Volume: 53, Issue:20
Synthesis and antiviral activity of novel chiral cyanoacrylate derivatives.
AID1251624Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by SRB assay2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Design, Synthesis, and Biological Activity of Sulfonamide Analogues of Antofine and Cryptopleurine as Potent and Orally Active Antitumor Agents.
AID741431Cytotoxicity against human HCT15 cells after 72 hrs by SRB assay2013Bioorganic & medicinal chemistry, Feb-15, Volume: 21, Issue:4
Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.
AID316822Growth inhibition of human HepG cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID610920Upregulation of CDT1 expression in human CL1-5 cells by cDNA microarray2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents.
AID610916Anticancer activity against human A549 cells after 72 hrs by sulforhodamine B assay2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents.
AID1092197In vivo antiviral activity against Tobacco mosaic virus (TMV) inoculated left side of Nicotiana tabacum L. leaves assessed as inactivation effect at 100 ug/mL co-incubated with virus measured after 3 to 4 days2012Journal of agricultural and food chemistry, Oct-17, Volume: 60, Issue:41
Design, synthesis, and anti-tobacco mosaic virus (TMV) activity of phenanthroindolizidines and their analogues.
AID291929Cytotoxicity against human DU145 cells by SRB microtiter plate assay2007Journal of medicinal chemistry, Jul-26, Volume: 50, Issue:15
Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
AID421641Anticancer activity against human KBVIN cells after 72 hrs by SRB assay2009Journal of medicinal chemistry, Aug-27, Volume: 52, Issue:16
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents.
AID610923Upregulation of Cdt1 expression in human CL1-5 cells at 0.01 ug/mL by RT-PCR analysis after 24 to 48 hrs by Western blot2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents.
AID316828Inhibition of GRE-mediated transcription in human HepG cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID1112987Antiviral activity against Tobacco mosaic virus (TMV) in tobacco plant leaf assessed as curative effect at 500 ug/ml after 3 to 4 days2013Journal of agricultural and food chemistry, Feb-06, Volume: 61, Issue:5
Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.
AID291928Cytotoxicity against human KB cells by SRB microtiter plate assay2007Journal of medicinal chemistry, Jul-26, Volume: 50, Issue:15
Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
AID291930Cytotoxicity against human ZR751cells by SRB microtiter plate assay2007Journal of medicinal chemistry, Jul-26, Volume: 50, Issue:15
Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
AID316829Ratio of IC50 for NF-kappaB-mediated transcription in human HepG cells to GI50 for human HepG2 cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID1251623Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by SRB assay2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Design, Synthesis, and Biological Activity of Sulfonamide Analogues of Antofine and Cryptopleurine as Potent and Orally Active Antitumor Agents.
AID698604Cytotoxicity against human DU145 cells after 2 hrs by methylene blue staining-based spectrophotometric analysis2012Journal of medicinal chemistry, Aug-09, Volume: 55, Issue:15
Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: design, synthesis, and mechanistic studies.
AID741238Cytotoxicity against human HCT116 cells after 72 hrs by SRB assay2013Bioorganic & medicinal chemistry, Feb-15, Volume: 21, Issue:4
Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.
AID311340Antiviral activity against Tobacco mosaic virus U1 at 1 ug/mL after 72 hrs by half leaf method2007Journal of natural products, Sep, Volume: 70, Issue:9
Benzylphenethylamine alkaloids from Hosta plantaginea with inhibitory activity against tobacco mosaic virus and acetylcholinesterase.
AID316825Inhibition of NF-kappaB-mediated transcription in human HepG cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID741429Cytotoxicity against human SKHEP1 cells after 72 hrs by SRB assay2013Bioorganic & medicinal chemistry, Feb-15, Volume: 21, Issue:4
Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.
AID316823Growth inhibition of human PANC1 cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID1251628Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by SRB assay2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Design, Synthesis, and Biological Activity of Sulfonamide Analogues of Antofine and Cryptopleurine as Potent and Orally Active Antitumor Agents.
AID1112991Antiviral activity against Tobacco mosaic virus (TMV) in tobacco plant leaf assessed as protection effect at 100 ug/ml after 3 to 4 days2013Journal of agricultural and food chemistry, Feb-06, Volume: 61, Issue:5
Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.
AID1112986Antiviral activity against Tobacco mosaic virus (TMV) in tobacco plant leaf assessed as curative effect at 100 ug/ml after 3 to 4 days2013Journal of agricultural and food chemistry, Feb-06, Volume: 61, Issue:5
Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.
AID336106Cytotoxicity against multidrug-resistant human KBV1 cells by MTS/PMS assay2002Journal of natural products, Sep, Volume: 65, Issue:9
In vitro cytotoxic activity of phenanthroindolizidine alkaloids from Cynanchum vincetoxicum and Tylophora tanakae against drug-sensitive and multidrug-resistant cancer cells.
AID292719Cytotoxicity against human A549 cells by SRB assay2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
Synthesis and structure-activity studies of antofine analogues as potential anticancer agents.
AID1176191Antiproliferative activity against human A549 cells after 72 hrs by ATPlite assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Synthesis and biological evaluation of (-)-6-O-desmethylcryptopleurine and analogs.
AID741210Cytotoxicity against human paclitaxel-resistant A549 cells after 72 hrs by SRB assay2013Bioorganic & medicinal chemistry, Feb-15, Volume: 21, Issue:4
Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.
AID698603Cytotoxicity against human KBVIN cells overexpressing P-gp after 2 hrs by methylene blue staining-based spectrophotometric analysis2012Journal of medicinal chemistry, Aug-09, Volume: 55, Issue:15
Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: design, synthesis, and mechanistic studies.
AID648632Antiproliferative activity against human A549 cells after 72 hrs by MTT assay2012European journal of medicinal chemistry, May, Volume: 51Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents.
AID421640Anticancer activity against human KB cells after 72 hrs by SRB assay2009Journal of medicinal chemistry, Aug-27, Volume: 52, Issue:16
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents.
AID610921Upregulation of Cdt1 expression in human CL1-5 cells at 0.01 ug/mL by RT-PCR analysis after 24 to 48 hrs by Western blot2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents.
AID648628Antiproliferative activity against human HL60 cells after 72 hrs by SRB assay2012European journal of medicinal chemistry, May, Volume: 51Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents.
AID316831Ratio of IC50 for AP1-mediated transcription in human HepG cells to GI50 for human HepG2 cells2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Structural analogs of tylophora alkaloids may not be functional analogs.
AID292717Cytotoxicity against human HCT116 cells by SRB assay2007Bioorganic & medicinal chemistry letters, Jan-01, Volume: 17, Issue:1
Synthesis and structure-activity studies of antofine analogues as potential anticancer agents.
AID610924Upregulation of Cdt1 expression in human CL1-5 cells at 0.01 ug/mL by RT-PCR analysis after 24 to 48 hrs2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Antitumor agents 288: design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents.
AID1251626Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by SRB assay2015Journal of medicinal chemistry, Oct-08, Volume: 58, Issue:19
Design, Synthesis, and Biological Activity of Sulfonamide Analogues of Antofine and Cryptopleurine as Potent and Orally Active Antitumor Agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's14 (25.93)29.6817
2010's35 (64.81)24.3611
2020's5 (9.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.36 (24.57)
Research Supply Index4.01 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other52 (96.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]